Monro, Inc. filed an 8-K on November 4, 2026, disclosing an amendment to its existing Rights Agreement that extends the plan's final expiration date by approximately one year to November 1, 2027.

Key Highlights

  • Amendment date: The Amendment to the Rights Agreement was entered into on November 4, 2026.
  • Original expiration extended: The final expiration date was extended from 5:00 p.m. Eastern Time on November 6, 2026, to 5:00 p.m. Eastern Time on November 1, 2027.
  • Original Rights Agreement: The underlying Rights Agreement was originally dated November 10, 2025, with Equiniti Trust Company, LLC serving as rights agent.
  • Board rationale: According to the filing, the Board determined to extend the expiration "to support the Company's ongoing review of strategic alternatives."
  • Purpose stated: The extension is described as intended "to preserve the Board's ability to conduct the review effectively and to protect the interests of the Company and its shareholders during the review."
  • Securities covered: The Rights Agreement relates to Rights to Purchase Series D Junior Participating Serial Preferred Stock, registered on NASDAQ:MNRO.

Monro Amends Shareholder Rights Plan Amid Strategic Alternatives Review

Monro, Inc. (NASDAQ:MNRO) reported on November 4, 2026, that it had entered into an amendment to its existing shareholder rights agreement with Equiniti Trust Company, LLC, the designated rights agent. The original Rights Agreement was dated November 10, 2025. Without the amendment, the Rights were set to expire at 5:00 p.m. Eastern Time on November 6, 2026. The Amendment shifts that deadline to 5:00 p.m. Eastern Time on November 1, 2027, according to the filing.

The filing states that the Company's Board of Directors determined to extend the expiration of the Rights Agreement "to support the Company's ongoing review of strategic alternatives." The Board characterized the extension as a measure intended to preserve its ability to conduct that review and to protect the interests of the Company and its shareholders during the process. The filing does not provide additional details about the nature or status of the strategic alternatives review.

Under the terms described in the filing, the Rights will expire at the new deadline unless they are "earlier redeemed, exchanged in full or terminated." The Amendment is attached to the filing as Exhibit 4.2. The filing was signed by Maureen E. Mulholland, EVP, Chief Legal Officer and Secretary of Monro, Inc., on November 4, 2026. The Company is incorporated in New York and headquartered at 295 Woodcliff Drive, Suite 202, Fairport, NY 14450.

What Was Disclosed

Monro, Inc. disclosed an amendment to its shareholder Rights Agreement extending the plan's expiration from November 6, 2026, to November 1, 2027. The Board cited an ongoing review of strategic alternatives as the basis for the extension.